文献速递泌尿生殖腹部MR

透明细胞可能性评分用于鉴别肾脏上皮样血管平滑肌脂肪瘤与透明细胞肾细胞癌

Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score.
PubMed 文献 · Abdom Radiol (NY) · 2023-09-25

该回顾性研究纳入27例上皮样血管平滑肌脂肪瘤和60例透明细胞肾细胞癌患者,共90个肾脏肿块,由两名放射科医师独立应用透明细胞可能性评分(ccLS)评分。ccLS在两组间分布差异有统计学意义(P < 0.001),以2分为阈值鉴别两者的准确率87.8%、敏感度95.0%、特异度73.3%、AUC 0.913,且评分分布不受肿瘤大小影响(P = 0.780)。

要点

  • ccLS鉴别上皮样血管平滑肌脂肪瘤与透明细胞肾细胞癌的AUC为0.913,准确率87.8%。
  • 上皮样血管平滑肌脂肪瘤73.3%为1–2分,透明细胞肾细胞癌76.7%为4–5分(P < 0.001)。
  • 以2分为阈值时敏感度95.0%、特异度73.3%、阳性预测值87.7%、阴性预测值88.0%。

核心结论

  • ccLS能以高准确性和高效率鉴别上皮样血管平滑肌脂肪瘤与透明细胞肾细胞癌。

研究设计与样本

  • 回顾性分析,纳入本机构术前接受MRI的27例上皮样血管平滑肌脂肪瘤患者和60例透明细胞肾细胞癌患者,共87例患者、90个肾脏肿块(上皮样血管平滑肌脂肪瘤与透明细胞肾细胞癌比例为1:2),由两名受过ccLS算法培训的放射科医师独立评分并评估观察者间一致性。

关键影像表现/征象

  • 上皮样血管平滑肌脂肪瘤组的ccLS评分为1–5分,其中73.3%为1–2分。
  • 透明细胞肾细胞癌组的ccLS评分为2–5分,其中76.7%为4–5分。
  • 两组ccLS评分分布差异有统计学意义(P < 0.001)。
  • ccLS评分在两种疾病间的分布不受肿瘤大小影响(P = 0.780)。

诊断标准与关键数值

  • 两名放射科医师应用ccLS鉴别上皮样血管平滑肌脂肪瘤与透明细胞肾细胞癌的观察者间一致性良好(k = 0.71)。
  • 以2分为阈值,ccLS鉴别上皮样血管平滑肌脂肪瘤与透明细胞肾细胞癌的准确率87.8%、敏感度95.0%、特异度73.3%、阳性预测值87.7%、阴性预测值88.0%,AUC为0.913。

临床应用与阅片要点

  • ccLS评分可用于术前MRI鉴别上皮样血管平滑肌脂肪瘤与透明细胞肾细胞癌。
  • ccLS评分分布不受肿瘤大小影响,小肾脏肿块(≤ 4 cm)与大肾脏肿块(> 4 cm)亚组间评分分布差异无统计学意义(P = 0.780)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Clear cell likelihood score (ccLS) may be a reliable diagnostic method for distinguishing renal epithelioid angiomyolipoma (EAML) and clear cell renal cell carcinoma (ccRCC). In this study, we aim to explore the value of ccLS in differentiating EAML from ccRCC.

METHODS: We performed a retrospective analysis in which 27 EAML patients and 60 ccRCC patients underwent preoperative magnetic resonance imaging (MRI) at our institution. Two radiologists trained in the ccLS algorithm scored independently and the consistency of their interpretation was evaluated. The difference of the ccLS score was compared between EAML and ccRCC in the whole study cohort and two subgroups [small renal masses (SRM; ≤ 4 cm) and large renal masses (LRM; > 4 cm)].

RESULTS: In total, 87 patients (59 men, 28 women; mean age, 55±11 years) with 90 renal masses (EAML: ccRCC = 1: 2) were identified. The interobserver agreement of two radiologists for the ccLS system to differentiate EAML from ccRCC was good (k = 0.71). The ccLS score in the EAML group and the ccRCC group ranged from 1 to 5 (73.3% in scores 1-2) and 2 to 5 (76.7% in scores 4-5), respectively, with statistically significant differences (P < 0.001). With the threshold value of 2, ccLS can distinguish EAML from ccRCC with the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 87.8%, 95.0%, 73.3%, 87.7%, and 88.0%, respectively. The AUC (area under the curve) was 0.913. And the distribution of the ccLS score between the two diseases was not affected by tumor size (P = 0.780).

CONCLUSION: The ccLS can distinguish EAML from ccRCC with high accuracy and efficiency.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Hao YW, Zhang Y, Guo HP, et al. Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score. Abdom Radiol (NY). 2023. PMID: 37747536. doi:10.1007/s00261-023-04034-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。